Novel allosteric modulation of the human 5-HT3A receptor by the clinically used drugs piperazine and hydroxyzine | ||
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca | |
| dc.conicet.organizacion | New College Of Florida | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca | |
| dc.contributor.author | Rodriguez Araujo, Noelia | |
| dc.contributor.author | Corradi, Jeremías | |
| dc.contributor.author | Bergé, Ignacio | |
| dc.contributor.author | Bouzat, Cecilia Beatriz | |
| dc.date.issued | 2026-09 | |
| dc.description.abstract | The 5-HT3 receptor is a serotonin-gated cation channel of the pentameric ligand-gated ion channel family andplays a key role in fast synaptic transmission within the central, peripheral, and enteric nervous systems. Dysregulationof this receptor has been linked to neurological, psychiatric, and gastrointestinal disorders. Whilecompetitive 5-HT3 antagonists, primarily setrons, are clinically used to alleviate gastrointestinal symptoms, thereis a growing interest in developing new negative allosteric modulators (NAMs) for this receptor. Here, we applieda drug-repositioning strategy targeting the human 5-HT3A receptor. Using macroscopic current recordings, weidentified a previously unrecognized NAM activity of two clinically used drugs, piperazine and its derivativehydroxyzine, on the 5-HT3A receptor. Computational analyses suggested two distinct binding sites at subunitinterfaces: one in the lower extracellular domain and another in the upper transmembrane domain. Functionalcharacterization of receptors carrying mutations at key residues within these sites (E75, E208, S248, D293)showed that some mutations abolished drug-induced inhibition, whereas others enhanced the inhibitory effect ofhydroxyzine. Altogether, these results validate the proposed allosteric sites and demonstrate that both contributeto the actions of these compounds. This work uncovers a new functional connection between 5-HT3A receptorsand piperazine-derived drugs, opening avenues for therapeutic repurposing. | es |
| dc.description.fil | Fil: Rodriguez Araujo, Noelia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina | |
| dc.description.fil | Fil: Corradi, Jeremías. New College Of Florida; Estados Unidos | |
| dc.description.fil | Fil: Bergé, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina | |
| dc.description.fil | Fil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Rodriguez Araujo, Noelia; Corradi, Jeremías; Bergé, Ignacio; Bouzat, Cecilia Beatriz; Novel allosteric modulation of the human 5-HT3A receptor by the clinically used drugs piperazine and hydroxyzine; Pergamon-Elsevier Science Ltd; Neuropharmacology; 301; 9-2026; 1-10 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0028-3908 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/299612 | |
| dc.journal.pagination | 1-10 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Neuropharmacology | es |
| dc.journal.volume | 301 | es |
| dc.language.iso | eng | es |
| dc.publisher | Pergamon-Elsevier Science Ltd | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://linkinghub.elsevier.com/retrieve/pii/S0028390826003710 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.neuropharm.2026.111196 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | 5-HT3 RECEPTOR | es |
| dc.subject | LIGAND-GATED ION CHANNEL | es |
| dc.subject | PATCH CLAMP | es |
| dc.subject | MACROSCOPIC CURRENTS | es |
| dc.subject.classification | Farmacología y Farmacia | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Novel allosteric modulation of the human 5-HT3A receptor by the clinically used drugs piperazine and hydroxyzine | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.4b67f5d6-875f-404e-86eb-67ea4ab082a1_B.pdf
- Tamaño:
- 4 MB
- Formato:
- Adobe Portable Document Format